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A case–control study of 1,466 urban adults in Ghana 
found that patients with type 2 diabetes mellitus had a 46% 
increased risk for infection with Plasmodium falciparum. In-
crease in diabetes mellitus prevalence may put more per-
sons at risk for malaria infection. 
I
n sub-Saharan Africa, infectious diseases remain the pre-
dominant cause of illness and death. Plasmodium falci-
parum malaria alone causes an estimated 1 million deaths 
annually (1). At the same time, sub-Saharan Africa faces 
the world’s highest increase in type 2 diabetes mellitus; ad-
aptation to Western lifestyles and genetic predispositions 
may accelerate this trend (2,3). A decade ago, type 2 dia-
betes mellitus prevalence in urban Ghana was 6.3% (4). By 
2030, ≈20 million affected persons may live in sub-Saharan 
Africa (2). Type 2 diabetes mellitus increases susceptibil-
ity to common infections (5). In sub-Saharan Africa, the 
emerging co-occurrence of type 2 diabetes mellitus and 
tropical infectious diseases thus may have substantial im-
plications. We describe prevalence of malaria infection in 
adults with and without type 2 diabetes mellitus residing 
in Kumasi, Ghana. Malaria transmission in Kumasi is low 
but patchy; mosquito breeding sites also occur in urban 
agricultural areas (6).
The Study
A case–control study of risk factors for type 2 dia-
betes and hypertension was conducted from August 2007 
through June 2008 at Komfo-Anokye Teaching Hospital, 
Kumasi, Ghana. The patients’ clinical and biochemical 
signs and symptoms were secondary objectives (I. Dan-
quah et al., unpub. data). The study protocol was ap-
proved by the Ethics Committee, University of Science 
and Technology, Kumasi, and participants gave informed 
written consent. 
Patients attending the diabetes (n = 495) or hyperten-
sion center (n = 451) were recruited. These patients pro-
moted participation as preliminary (i.e., to be conﬁ  rmed) 
controls to community members, neighbors, and friends (n 
= 222). Further preliminary controls were recruited from 
the outpatient department (n = 150) and among hospital 
staff (n = 148).
Participants were told to fast, abstain from alcohol and 
nicotine use, and avoid stressful and physical activities be-
ginning at 10:00 PM the day before examination. On the day 
of examination, participants were asked about medical his-
tory and socioeconomic background, underwent physical 
examination, and provided venous blood and urine samples 
for laboratory testing. 
Fasting plasma glucose (hereafter referred to as glu-
cose concentration; ﬂ  uoride plasma at 4°C) and hemoglo-
bin (Hb) concentrations were measured (Glucose-201+, 
B-Hemoglobin; HemoCue, Angelhom, Sweden). Irrespec-
tive of symptoms, malaria parasites were counted per 500 
leukocytes on Giemsa-stained thick blood ﬁ  lms. Plasmo-
dium infection and species were ascertained by PCR that 
included positive and negative controls (7).
Patients with type 2 diabetes mellitus were deﬁ  ned as 
those receiving documented treatment with antidiabetes 
medication or having a glucose concentration >7 mmol/L 
(8); patients with hypertension were deﬁ  ned as those re-
ceiving documented antihypertension treatment or having 
mean blood pressure >140/90 mm Hg for 3 measurements 
(9). Controls had neither condition.
Between-group comparisons were performed by the 
Mann-Whitney U, χ2, and Fisher exact tests. Logistic re-
gression produced adjusted odds ratios (aORs), and 95% 
conﬁ  dence intervals (CIs).
Of the 1,466 study participants, 675 (46%) had type 
2 diabetes (Table 1). Among these, 655 (97.0%) received 
antidiabetes treatment, but 317 (47.0%) had increased glu-
cose concentration (>7 mmol/L). The 414 patients with hy-
pertension but not diabetes and 377 controls with neither 
condition were grouped despite differences, e.g., in age and 
socioeconomic parameters (data not shown); however, glu-
cose concentration was similar for the 2 groups (mean 4.51 
vs. 4.56 mmol/L; p = 0.53).
According to microscopic examination, 13 (0.9%) of 
all participants had malaria parasites at low density (me-
dian 880/μL, range 80–4,960/μL). Reexamination by PCR 
showed that 206 (14.1%) were infected with Plasmodium 
spp., largely P. falciparum (189, 12.9%). Infected persons 
were afebrile, but mean hemoglobin was reduced (–0.4 g/
dL; p = 0.004).
More Plasmodium spp. infections were observed in 
persons with type 2 diabetes mellitus than in those without 
the disease (Table 1); most infections were caused by P. 
falciparum (16% vs. 10%; p = 0.001). This difference was 
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DOI: 10.3201/eid1610.100399not attributable to recent antimalarial medication (7 per-
sons with type 2 diabetes mellitus vs. 13 persons without 
type 2 diabetes mellitus; p = 0.32), and, notably, 74/524 
(14.1%) of the patients with type 2 diabetes mellitus who 
took metformin-based drugs were infected compared with 
34/131 (26.0%) of those who did not (p = 0.01). Among 
controls and patients with hypertension, the P. falciparum 
prevalence was similar (35/377, 9.3% for controls; 46/411, 
11.2% for patients with hypertension; p = 0.38), and in 
each case, it was comparatively higher among patients with 
type 2 diabetes mellitus (p = 0.003 for controls; p = 0.03 for 
patients with hypertension).
Several factors that differed between persons with and 
those without diabetes mellitus (Table 1) were associated 
with P. falciparum infection (Table 2). However, age-ad-
justed multivariate analysis conﬁ  rmed that the odds of P. 
falciparum infection in patients with type 2 diabetes mel-
litus were increased (aOR 1.46; Table 2). This risk increase 
was still discernible in the same model comparing patients 
with type 2 diabetes mellitus with controls (aOR 1.68, 95% 
CI 1.06–2.65; p = 0.027) or patients with hypertension 
(aOR 1.38, 95% CI 0.94–2.02; p = 0.096), or when separat-
ing into metropolitan area (aOR 1.67, 95% CI 1.12–2.48; p 
= 0.01) and other residence (aOR 1.32, 95% CI 0.76–2.29; 
p = 0.33).
According to the multivariate model, exchanging type 
2 diabetes mellitus with glucose concentration showed 
that each mmol/L increase in blood glucose increased the 
risk for P. falciparum infection by 5% (aOR 1.05, 95% CI 
1.02–1.09; p = 0.002). Among patients with type 2 diabetes 
mellitus, a stepwise approach identiﬁ  ed 8.6 mmol/L glu-
cose concentration as the signiﬁ  cant threshold of risk in-
crease (aOR 1.63, 95% CI 1.07–2.48; p = 0.02).
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Table 1. Demographic and clinical characteristics of 1,466 urban residents of Kumasi, Ghana, 2007–2008* 
Characteristics
Persons with type 2 diabetes 
mellitus, n = 675 
Persons without diabetes, 
n = 791  p value 
Age, y, mean (range)  54.7 (18–92)  47.1 (18–100)  <0.0001 
Male gender  171 (25.3)  182 (23.0)  0.299 
Wealth score <25th percentile† 265 (39.6)  271 (34.3)  0.044 
Illiteracy  308 (45.8)  206 (26.1)  <0.0001 
Formal education, none  240 (35.7)  130 (16.5)  <0.0001 
Crowded living condition‡ 177 (26.7)  120 (15.3)  <0.0001 
Smoking, current or quit  49 (7.3)  35 (4.4)  0.024 
Akan ethnicity  592 (87.8)  685 (86.6)  0.480 
Residence
  Kumasi metropolitan area  476 (70.8)  603 (76.2) 
  Kumasi suburbs  174 (25.9)  162 (20.5) 
 Elsewhere§ 22 (3.3)  26 (3.3)  0.048 
Occupation
  Public servant  44 (6.5)  194 (24.6) 
  Trader  198 (29.5)  190 (24.1) 
  Farmer  65 (9.7)  48 (6.1) 
  Unemployed  248 (36.9)  138 (17.5) 
  Other¶  117 (17.4)  218 (27.7)  <0.0001 
FPG, mmol/L, mean (range)  8.3 (1.3–37.1)  4.5 (2.9–7.0)  <0.0001 
Hemoglobin, g/dL, mean (range)  12.9 (5.8–19.1)  13.6 (4.9–19.1)  <0.0001 
Fever, >37.5°C  2 (0.3)  4 (0.5)  0.693 
History of fever, preceding week  95 (14.1)  93 (11.8)  0.182 
Respiratory tract infection  5 (0.7)  11 (1.4)  0.232 
Urinary tract infection# 14 (2.1)  7 (0.9)  0.076 
Plasmodium spp. infection, by microscopy  5 (0.7)  8 (1.0)  0.582 
Parasite density, per μL, median (range)  1,160 (160–2,480)  860 (80–4,960)  0.770 
Plasmodium spp. infection, by PCR 
 Plasmodium  spp.  117 (17.4)  89 (11.3)  0.001 
 P.  falciparum 108 (16.0)  81 (10.3)  0.001 
 P.  malariae 14 (2.1)  9 (1.1)  0.205 
 P.  ovale 8 (1.2)  7 (0.9)  0.611 
*Values are no. (%) unless otherwise indicated. p values were calculated by Mann-Whitney U test or Fisher exact test, as applicable. FPG, fasting plasma 
glucose concentration.  
†<25th percentile of a calculated index of 11 markers of wealth: electricity, pipe-borne water, radio, fan, cupboard, television, bicycle, motorbike, 
refrigerator, car/truck/tractor, cattle.  
‡>75th percentile of the number of persons living in the household.  
§Hinterland and environs. 
¶Includes casual laborer, artisan, and others.  
#By nitrite-positive urine dipstick test (Combur 10, Roche Diagnostics, Mannheim, Germany). Type 2 Diabetes and Malaria Infection
Conclusions
This study provides evidence for increased risk for P. 
falciparum infection in patients with type 2 diabetes mel-
litus (Table 2). Most infections were detected by PCR ex-
clusively, and all were asymptomatic.
Submicroscopic and asymptomatic P. falciparum in-
fections are common in areas where malaria is endemic. In 
adults, PCR may identify up to 50% of infections, although 
only a few infections are diagnosed by microscopy (10). 
These submicroscopic infections tend to increase in areas 
of low endemicity and with patient age (10).
An increased risk for P. falciparum infection in 
persons with diabetes mellitus might become clinically 
relevant (and microscopically detectable) under several 
conditions. The impact of semi-immunity on controlling 
parasitemia may weaken with advancing type 2 diabetes 
mellitus and immune dysfunction (5), as suggested by the 
observed risk increase with increasing glucose concentra-
tion. Conversely, children who lack semi-immunity but 
have more severe type 1 diabetes mellitus may be particu-
larly prone to malaria. Such vulnerability is also conceiv-
able for women with gestational diabetes whose immune 
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 16, No. 10, October 2010  1603 





infection, no. (%) 
Univariate analysis  Multivariate analysis 
OR (95% CI)  p value  aOR (95% CI)  p value 
Diabetes mellitus type 2 
 No  791 81  (10.3)  1
  Yes  675 108 (16.0)  1.67 (1.22–2.27)  0.001  1.46 (1.06–2.03)  0.021 
Gender 
 F  1,113  124  (11.2)  1
  M  353 65 (18.5)  1.80 (1.29–2.50)  <0.0001  2.13 (1.50–3.03)  <0.0001 
Wealth score 
 >25th percentile  923 94 (10.2) 
  <25th percentile †  536 94 (17.6)  1.88 (1.38–2.56)  <0.0001  1.76 (1.27–2.42)  0.001 
Literacy 
  Able to read  947 103 (10.9)  1
  Unable to read  514 85 (16.6)  1.63 (1.20–2.23)  0.002  1.59 (1.11–2.28)  0.011 
Formal education 
 Any  1,091  126  (11.6)  1
  None  370 62 (16.8)  1.54 (1.11–2.15)  0.010 
Living condition 
 Uncrowded  1,147  133  (11.6)  1
  Crowded‡  297 52 (17.5)  1.61 (1.14–2.29)  0.007 
Smoking
 Never  1,380  171  (12.4)  1
  Current or quit  84 18 (21.4)  1.92 (1.11–3.32)  0.019 
Ethnicity
 Akan  1,277  156  (12.3)  1
  Others  188 33 (17.6)  1.52 (1.01–2.30)  0.045 
Residence
  Kumasi metropolitan  1,079  121 (11.2)  1
  Kumasi outskirts  336 64 (19.2)  1.87 (1.34–2.61)  <0.0001 
 Elsewhere  § 48 4 (8.3)  0.72 (0.25–2.03)  0.533 
Occupation
  Public servant  238 17 (7.1)  1
  Trader  388 50 (12.9)  1.92 (1.08–3.42)  0.026 
  Farmer  113 34 (30.6)  5.74 (3.04–10.86)  <0.0001 
  Other¶  335 38 (11.3)  1.66 (0.92–3.02)  0.095 
  Unemployed  386 49 (12.8)  1.90 (1.07–3.39)  0.029 
*OR, odds ratio; CI, confidence interval; aOR, adjusted odds ratio. Age and gender were a priori included in the multivariate model. Further variables for 
inclusion in the model were identified by factor analysis excluding multicollinear parameters (1: retained diabetes, excluded occupation; 2: retained 
literacy, excluded education, smoking; 3: retained wealth, excluded living condition, ethnicity). The same model results from a logistic regression analysis 
initially including all above listed parameters, and then removing in a stepwise backward fashion all factors not associated with P. falciparum infection in 
multivariate analysis (p > 0.05). Inserting any of the excluded variables back into the model did not change the aOR of patients with type 2 diabetes 
mellitus by >7% each, suggesting the absence of substantial confounding. Leaving all parameters in the model yielded an aOR for patients with type 2 
diabetes mellitus of 1.36 (95% CI, 0.98–1.90; p = 0.07). Alternatively, propensity score adjustment of that analysis, i.e. reducing covariates into a single 
variable, produced aOR = 1.41 (95% CI, 1.02–1.95; p = 0.04). 
†<25th percentile of a calculated index of 11 markers of wealth. 
‡Crowded living condition, >75th percentile of the number of persons living in the household, i.e., n>8.  
§Hinterland and environs. 
¶Includes casual labourer, artisan, and others. systems are relatively naive with regard to pregnancy-spe-
ciﬁ  c P. falciparum (11). Moreover, low-level infections 
in patients with type 2 diabetes mellitus may constitute an 
unrecognized infectious reservoir in areas where malaria 
is endemic (10). The lowered P. falciparum prevalence 
under metformin medication accords with the biguanides’ 
antimalarial efﬁ  cacy (12).
Our data stem from a study that was not designed to 
assess inﬂ  uences on P. falciparum infection in a heteroge-
neous population. Multivariate analysis cannot exclude un-
measured confounders, and association does not mean cau-
sality. As a limitation, factors inﬂ  uencing infection were 
not speciﬁ  cally identiﬁ  ed during recruitment and thus were 
not included in analysis. Also, despite adjusting for proxy 
indicators, e.g., wealth, exposure to infection might still 
have differed between the study groups, considering the 
patchy malaria transmission in Kumasi (6). Nonetheless, 
increased odds of P. falciparum in patients with type 2 dia-
betes mellitus were found after stratiﬁ  cation by subgroups 
or residence. Ultimate corroboration would need a prospec-
tive, longitudinal study controlling for exposure (possibly 
monitored by serologic markers of transmission).
Although the actual reasons for the increase of P. fal-
ciparum infection are unclear, the risk increase with rising 
glucose concentration is a sign of biologic plausibility. Such 
risk could result from impaired defense against liver and/
or blood-stage parasites and from prolonged persistence. 
In type 2 diabetes mellitus, decreased T cell–mediated im-
munity but limited impact on humoral responses are dis-
cussed (5). Mechanistically, increased glucose availability 
may feed P. falciparum growth as seen in vitro (13). Also, 
patients with diabetes might receive more infectious mos-
quito bites: olfactory signals mediate mosquito attraction 
(14), and these, including expiration, are subtly altered in 
persons with type 2 diabetes mellitus (15).
The rapid proliferation of type 2 diabetes mellitus in 
sub-Saharan Africa may put an increasing number of per-
sons at risk for Plasmodium infection and malaria. Thus, 
the magnitude of both diabetes mellitus and malaria in sub-
Saharan Africa warrants further investigation into the rel-
evance and causes of our ﬁ  nding
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